Drug profile

The FDA adverse-event record for Canine Distemper-Adenovirus Type 2-Coronavirus-Parainfluenza-Parvovirus Vaccine, Mlv-Kv, Leptospira Canicola-Grippotyphosa-Ictero-Pomona Bacterial Extract

46 adverse-event reports submitted to the FDA Center for Veterinary Medicine reference Canine Distemper-Adenovirus Type 2-Coronavirus-Parainfluenza-Parvovirus Vaccine, Mlv-Kv, Leptospira Canicola-Grippotyphosa-Ictero-Pomona Bacterial Extract. See the species affected, top reactions, and outcomes below.

46
adverse-event reports
23.9%
death-coded share
Dog
most-reported species
11
Vomiting - top reaction
Verify with FDA CVM →
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
46
Total Reports
11
Deaths Reported
23.9%
Death Rate

Active Ingredients

Canine Distemper-Adenovirus Type 2-Coronavirus-Parainfluenza-Parvovirus Vaccine, Mlv-Kv, Leptospira Canicola-Grippotyphosa-Ictero-Pomona Bacterial Extract

Administration Routes

SubcutaneousParenteralUnknownOther

Species Affected

Dog 45
Unknown 1

Most Affected Breeds

Retriever - Golden 5
Boxer (German Boxer) 5
Chihuahua 5
Pit Bull 4
Retriever - Labrador 4
Poodle (unspecified) 3
Dog (unknown) 2
Rottweiler 2
Retriever (unspecified) 2
Beagle 2

Most Reported Reactions

Vomiting 11
Death 8
Lack of efficacy (virus) - parvovirus (including feline panleukopenia) 8
Seizure NOS 6
Diarrhoea 6
Anaphylactoid reaction 5
Not eating 5
Anaemia NOS 4
Weight gain 3
Ataxia 3
Other abnormal test result NOS 3
Death by euthanasia 3

Outcome Breakdown

Outcome Unknown
16 (35.6%)
Ongoing
10 (22.2%)
Recovered/Normal
8 (17.8%)
Died
8 (17.8%)
Euthanized
3 (6.7%)

Canine Distemper-Adenovirus Type 2-Coronavirus-Parainfluenza-Parvovirus Vaccine, Mlv-Kv, Leptospira Canicola-Grippotyphosa-Ictero-Pomona Bacterial Extract Adverse Event Insights

46 reports name Canine Distemper-Adenovirus Type 2-Coronavirus-Parainfluenza-Parvovirus Vaccine, Mlv-Kv, Leptospira Canicola-Grippotyphosa-Ictero-Pomona Bacterial Extract; 11 recorded a death outcome (23.9% of reported events, not a population-level mortality rate). Active ingredient: Canine Distemper-Adenovirus Type 2-Coronavirus-Parainfluenza-Parvovirus Vaccine, Mlv-Kv, Leptospira Canicola-Grippotyphosa-Ictero-Pomona Bacterial Extract. Administration routes: Subcutaneous, Parenteral, Unknown, Other.

By species: Dog (45 reports), Unknown (1 reports). By breed: Retriever - Golden (5), Boxer (German Boxer) (5), Chihuahua (5).

Leading clinical signs: Vomiting (11), Death (8), Lack of efficacy (virus) - parvovirus (including feline panleukopenia) (8), Seizure NOS (6). Outcome, 45 coded reports: Outcome Unknown leads at 35.6%.

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. This page draws directly on FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.